The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis

by Rikke Hjortebjerg, Karen L. Thomsen, Jørgen Agnholt, Jan Frystyk
Published 2019-06-01

Effectiveness of interdisciplinary combined dermatology–gastroenterology–rheumatology clinical care compared to usual care in patients with immune-mediated inflammatory diseases: a...

by Trine Bay Laurberg, Anders Dige, Kasper Fjellhaugen Hjuler, Lars Iversen, Jørgen Agnholt, Louise Faurskov Møller
Published 2021-04-01

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn’s Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab

by Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt
Published 2020-11-01

Seven Weeks of High-Dose Vitamin D Treatment Reduces the Need for Infliximab Dose-Escalation and Decreases Inflammatory Markers in Crohn’s Disease during One-Year Follow-Up

by Mia Bendix, Anders Dige, Søren Peter Jørgensen, Jens Frederik Dahlerup, Bo Martin Bibby, Bent Deleuran, Jørgen Agnholt
Published 2021-03-01

Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn’s Disease

by Anders Dige, Maria K. Magnusson, Claus Uhrenholt, Tue Kruse Rasmussen, Tue Kragstrup, Lena Öhman, Jens Dahlerup, Jørgen Agnholt
Published 2018-01-01

Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.

by Sidsel Støy, Thomas Damgaard Sandahl, Anders Kirch Dige, Jørgen Agnholt, Tue Kruse Rasmussen, Henning Grønbæk, Bent Deleuran, Hendrik Vilstrup
Published 2013-01-01

Infliximab induces clonal expansion of γδ-T cells in Crohn's disease: a predictor of lymphoma risk?

by Jens Kelsen, Anders Dige, Heinrich Schwindt, Francesco D'Amore, Finn S Pedersen, Jørgen Agnholt, Lisbet A Christensen, Jens F Dahlerup, Christian L Hvas
Published 2011-03-01

Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study.

by Stine Hald, Anne Grethe Schioldan, Mary E Moore, Anders Dige, Helle Nygaard Lærke, Jørgen Agnholt, Knud Erik Bach Knudsen, Kjeld Hermansen, Maria L Marco, Søren Gregersen, Jens F Dahlerup
Published 2016-01-01

Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients

by Ane Bjerg Christensen, Anders Dige, Johan Vad-Nielsen, Christel R. Brinkmann, Mia Bendix, Lars Østergaard, Martin Tolstrup, Ole S. Søgaard, Thomas A. Rasmussen, Jens Randel Nyengaard, Jørgen Agnholt, Paul W. Denton
Published 2015-01-01